1. Home
  2. EZPW vs PGEN Comparison

EZPW vs PGEN Comparison

Compare EZPW & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EZCORP Inc. Non Voting

EZPW

EZCORP Inc. Non Voting

HOLD

Current Price

$30.21

Market Cap

2.0B

ML Signal

HOLD

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$6.25

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EZPW
PGEN
Founded
1989
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.6B
IPO Year
1996
2013

Fundamental Metrics

Financial Performance
Metric
EZPW
PGEN
Price
$30.21
$6.25
Analyst Decision
Buy
Buy
Analyst Count
3
5
Target Price
$30.67
$8.33
AVG Volume (30 Days)
856.7K
3.7M
Earning Date
05-12-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
29.09
N/A
EPS
1.17
N/A
Revenue
$747,954,000.00
$230,981,000.00
Revenue This Year
$25.40
$1,115.92
Revenue Next Year
$11.33
$81.04
P/E Ratio
$24.93
N/A
Revenue Growth
2.39
N/A
52 Week Low
$13.96
$1.70
52 Week High
$37.13
$6.04

Technical Indicators

Market Signals
Indicator
EZPW
PGEN
Relative Strength Index (RSI) 41.85 65.51
Support Level $27.86 $3.96
Resistance Level $36.88 $6.04
Average True Range (ATR) 1.66 0.31
MACD -0.34 0.04
Stochastic Oscillator 26.59 79.59

Price Performance

Historical Comparison
EZPW
PGEN

About EZPW EZCORP Inc. Non Voting

EZCORP Inc is a United States-based company engaged in offering pawn loans in the United States and Mexico. It also offers short-term unsecured loans and other consumer financial products, and buys and sells second-hand goods. The operating segments of the company are U.S. Pawn, Latin America Pawn, and Other Investments. The U.S. Pawn segment includes all pawn activities in the United States. The Latin America Pawn segment includes all pawn activities in Mexico and other parts of Latin America. The company generates revenue from merchandise sales, jewelry scrapping sales, and pawn service charges, of which key revenue is derived from the merchandise sales, which are mainly collateral forfeited from pawn lending operations and used merchandise purchased from the customers.

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

Share on Social Networks: